Cargando…

Amyloid A amyloidosis with subcutaneous drug abuse

Introduction: Amyloid A (AA) amyloidosis is a systemic form of amyloidosis secondary to chronic infections and inflammatory disorders. An acute-phase protein produced by the liver, serum amyloid A (SAA) is the precursor of AA amyloid fibrils. AA amyloid deposition occurs predominantly in the kidneys...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza, Jair Munoz, Peev, Vasil, Ponce, Mario A, Thomas, David B, Nayer, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nickan Research Institute 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206034/
https://www.ncbi.nlm.nih.gov/pubmed/25340157
http://dx.doi.org/10.12861/jrip.2014.06
_version_ 1782340758602252288
author Mendoza, Jair Munoz
Peev, Vasil
Ponce, Mario A
Thomas, David B
Nayer, Ali
author_facet Mendoza, Jair Munoz
Peev, Vasil
Ponce, Mario A
Thomas, David B
Nayer, Ali
author_sort Mendoza, Jair Munoz
collection PubMed
description Introduction: Amyloid A (AA) amyloidosis is a systemic form of amyloidosis secondary to chronic infections and inflammatory disorders. An acute-phase protein produced by the liver, serum amyloid A (SAA) is the precursor of AA amyloid fibrils. AA amyloid deposition occurs predominantly in the kidneys, spleen, adrenal glands, liver and gastrointestinal tract. The manifestations of AA amyloidosis involving the kidneys include proteinuria, tubular dysfunction and progressive loss of renal function. Case: We report a 47-year-old drug addict who developed AA amyloidosis as a result of recurrent suppurative skin infections secondary to subcutaneous drug injection. Elevated C-reactive protein concentrations attested to the presence of a chronic systemic inflammatory state. He suffered from the nephrotic syndrome and insidious loss of renal function. Isosthenuria and glycosuria were indicative of renal tubular dysfunction. Renal biopsy demonstrated AA amyloidosis involving the glomeruli, tubular basement membranes and blood vessel walls. Conclusion: Superimposed acute tubular necrosis due to concomitant endocarditis and cocaine use accelerated his renal disease. Case presentation is followed by a brief discussion of clinical features, natural history and outcome of AA amyloidosis with a particular emphasis on AA amyloidosis as a complication of subcutaneous drug abuse.
format Online
Article
Text
id pubmed-4206034
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nickan Research Institute
record_format MEDLINE/PubMed
spelling pubmed-42060342014-10-22 Amyloid A amyloidosis with subcutaneous drug abuse Mendoza, Jair Munoz Peev, Vasil Ponce, Mario A Thomas, David B Nayer, Ali J Renal Inj Prev Case Report Introduction: Amyloid A (AA) amyloidosis is a systemic form of amyloidosis secondary to chronic infections and inflammatory disorders. An acute-phase protein produced by the liver, serum amyloid A (SAA) is the precursor of AA amyloid fibrils. AA amyloid deposition occurs predominantly in the kidneys, spleen, adrenal glands, liver and gastrointestinal tract. The manifestations of AA amyloidosis involving the kidneys include proteinuria, tubular dysfunction and progressive loss of renal function. Case: We report a 47-year-old drug addict who developed AA amyloidosis as a result of recurrent suppurative skin infections secondary to subcutaneous drug injection. Elevated C-reactive protein concentrations attested to the presence of a chronic systemic inflammatory state. He suffered from the nephrotic syndrome and insidious loss of renal function. Isosthenuria and glycosuria were indicative of renal tubular dysfunction. Renal biopsy demonstrated AA amyloidosis involving the glomeruli, tubular basement membranes and blood vessel walls. Conclusion: Superimposed acute tubular necrosis due to concomitant endocarditis and cocaine use accelerated his renal disease. Case presentation is followed by a brief discussion of clinical features, natural history and outcome of AA amyloidosis with a particular emphasis on AA amyloidosis as a complication of subcutaneous drug abuse. Nickan Research Institute 2013-11-02 /pmc/articles/PMC4206034/ /pubmed/25340157 http://dx.doi.org/10.12861/jrip.2014.06 Text en Copyright © 2014 The Author(s); Published by Nickan Research Institute http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mendoza, Jair Munoz
Peev, Vasil
Ponce, Mario A
Thomas, David B
Nayer, Ali
Amyloid A amyloidosis with subcutaneous drug abuse
title Amyloid A amyloidosis with subcutaneous drug abuse
title_full Amyloid A amyloidosis with subcutaneous drug abuse
title_fullStr Amyloid A amyloidosis with subcutaneous drug abuse
title_full_unstemmed Amyloid A amyloidosis with subcutaneous drug abuse
title_short Amyloid A amyloidosis with subcutaneous drug abuse
title_sort amyloid a amyloidosis with subcutaneous drug abuse
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206034/
https://www.ncbi.nlm.nih.gov/pubmed/25340157
http://dx.doi.org/10.12861/jrip.2014.06
work_keys_str_mv AT mendozajairmunoz amyloidaamyloidosiswithsubcutaneousdrugabuse
AT peevvasil amyloidaamyloidosiswithsubcutaneousdrugabuse
AT poncemarioa amyloidaamyloidosiswithsubcutaneousdrugabuse
AT thomasdavidb amyloidaamyloidosiswithsubcutaneousdrugabuse
AT nayerali amyloidaamyloidosiswithsubcutaneousdrugabuse